Get the Stockscreener App
2.44
4.95%
0.115
Pre-market:
2.61
0.17
+6.97%
Alzamend Neuro Inc stock is traded at $2.44, with a volume of 79,216.
It is up +4.95% in the last 24 hours and up +9.91% over the past month.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
See More
Previous Close:
$2.325
Open:
$2.36
24h Volume:
79,216
Relative Volume:
0.71
Market Cap:
$8.84M
Revenue:
-
Net Income/Loss:
$-6.24M
P/E Ratio:
-0.4369
EPS:
-5.5853
Net Cash Flow:
$-8.09M
1W Performance:
+3.39%
1M Performance:
+9.91%
6M Performance:
-28.24%
1Y Performance:
-79.92%
1-Day Range:
$2.31
$2.47
1-Week Range:
$2.21
$2.47
52-Week Range:
$2.06
$12.60
Alzamend Neuro Inc Stock (ALZN) Company Profile
Name
Alzamend Neuro Inc
Sector
Industry
Phone
844-722-6333
Address
3500 LENOX RD. NE, ATLANTA
Compare ALZN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALZN
Alzamend Neuro Inc
|
2.44 | 8.84M | 0 | -6.24M | -8.09M | -5.5853 |
|
ARGX
Argen X Se Adr
|
918.53 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.52 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
201.62 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
363.92 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
725.34 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Alzamend Neuro Inc Stock (ALZN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-21 | Initiated | Ascendiant Capital Markets | Buy |
Alzamend Neuro Inc Stock (ALZN) Latest News
Can Alzamend Neuro Inc. stock sustain revenue growthWeekly Stock Report & Daily Oversold Bounce Ideas - newser.com
What margin trends mean for Alzamend Neuro Inc. stockJuly 2025 Market Mood & AI Forecasted Entry/Exit Points - newser.com
Multi asset correlation models including Alzamend Neuro Inc.Oil Prices & Fast Exit/Entry Strategy Plans - newser.com
Why Alzamend Neuro Inc. stock could see breakout soonMarket Volume Report & Entry Point Confirmation Signals - newser.com
Will Alzamend Neuro Inc. stock reach all time highs in 2025Weekly Volume Report & High Yield Equity Trading Tips - newser.com
What analyst consensus says on Alzamend Neuro Inc. stockTrade Analysis Summary & Scalable Portfolio Growth Ideas - newser.com
Alzamend Neuro announces passing of board member Andrew H. Woo - Investing.com
Alzamend Neuro Mourns Loss of Director Andrew Woo - TipRanks
Alzamend Neuro Announces Passing of Board Member Andrew H. Woo - TradingView
Is Alzamend Neuro Inc a good long term investmentSector ETF Performance & Add These Before Everyone Else Does - earlytimes.in
How Alzamend Neuro Inc. stock reacts to job market dataJobs Report & AI Driven Stock Movement Reports - newser.com
Published on: 2025-11-16 06:02:28 - newser.com
Will Alzamend Neuro Inc. stock remain a Wall Street favoriteJuly 2025 Recap & Technical Buy Zone Confirmations - newser.com
Historical volatility pattern of Alzamend Neuro Inc. visualizedJuly 2025 Rallies & Fast Exit and Entry Strategy Plans - newser.com
Will Alzamend Neuro Inc. stock go up soonTrade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
Comparing Alzamend Neuro Inc. in custom built stock radarsJuly 2025 Breakouts & Real-Time Volume Analysis - newser.com
Alzamend Neuro Inc. stock trend outlook and recovery pathWeekly Trade Review & Accurate Intraday Trade Tips - newser.com
Published on: 2025-11-14 01:12:44 - newser.com
Can Alzamend Neuro Inc. stock outperform in 2025 bull marketPortfolio Value Report & Daily Technical Stock Forecast Reports - newser.com
Published on: 2025-11-13 14:48:36 - newser.com
Will Alzamend Neuro Inc. stock rally after Fed decisionsBull Run & Real-Time Chart Breakout Alerts - newser.com
Published on: 2025-11-12 22:19:06 - newser.com
What earnings revisions data tells us about Alzamend Neuro Inc.Short Setup & Smart Money Movement Alerts - newser.com
Is Alzamend Neuro Inc. stock supported by innovation pipeline2025 Trade Ideas & Expert Verified Stock Movement Alerts - newser.com
How to build a dashboard for Alzamend Neuro Inc. stock2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com
What to do if you’re stuck in Alzamend Neuro Inc.Weekly Profit Recap & AI Driven Price Predictions - newser.com
Chart based exit strategy for Alzamend Neuro Inc.Portfolio Performance Report & Long-Term Investment Growth Plans - newser.com
Is Alzamend Neuro Inc. stock recession proofPortfolio Gains Report & Safe Entry Zone Identification - newser.com
Alzamend Neuro Inc Stock (ALZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.08%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):